For example, it has been reported that inhibition of PPP2R1A radiosensitizes pancreatic cancer via activation of CDC25C/CDK1, thus, PPP2R1A is a target gene for local therapy of pancreatic cancer [17]. This evidence concerns the gene PPP2R1A and pancreatic neoplasm.